As of June 30, 2023, Wave had $173.0 million in cash and cash equivalents, as compared to $88.5 million as of December 31, 2022. The company expects that its current cash and cash equivalents will be sufficient to fund operations into 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on WVE:
- Wave Life Sciences Reports Second Quarter 2023 Financial Results and Provides Business Update
- Wave Life Sciences Second Quarter 2023 Financial Results Scheduled for August 3, 2023
- Wave Life Sciences initiated with an Outperform at Raymond James
- Wave Life Sciences joins Russell 2000, Russell 3000 Indexes
- Wave Life Sciences Joins the Russell 2000® and Russell 3000® Indexes